Equal benefits to our residential courses, without the travel.
View CoursesMeeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-4 November 2021
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021
Regulatory update - EMA encourages companies to submit type I variations for 2021 in November 2021
Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia
The UK GLPMA hold periodic meetings with stakeholders. The minutes of the last meeting can be found here UK GLPMA Consultative committee meeting minutes May 2021
Medicines: licensing time-based performance measures
The PIC/S Working Group on Veterinary Medicinal Products (VMP), led by Grégory Verdier (France / ANSES), and the EMA GMP/GDP Inspectors Working Group have jointly developed two concept papers on the revision of Annex 4 (manufacture of veterinary medicinal products other than immunologicals) and Annex 5 (manufacture of immunological veterinary medicinal products) of the EU-PIC/S GMP Guide.
International organisations, vaccine manufacturers take stock of COVID-19 vaccine roll out, share views for 2022
Invitation to the 4th public stakeholder meeting on COVID-19 therapeutics and vaccines in the EU
The antiviral was found to be safe and effective following a stringent review of the available evidence.